SCHEDULE: Vanguard Group Divests Nu Skin Stake to Zero

The Vanguard Group has filed an amended Schedule 13G, reporting zero beneficial ownership in Nu Skin Enterprises Inc. common stock following an internal realignment.

Summary

• The Vanguard Group filed an Amendment No. 17 to Schedule 13G regarding Nu Skin Enterprises Inc. common stock.
• The filing reports 0% beneficial ownership of Nu Skin Enterprises Inc. common stock by The Vanguard Group.
• This change is attributed to an internal realignment within The Vanguard Group, Inc. on January 12, 2026.
• Following the realignment, certain subsidiaries or business divisions will now report beneficial ownership separately.
• The Vanguard Group, Inc. no longer has beneficial ownership over securities held by these disaggregated entities.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, primarily a procedural update reflecting an internal organizational change at The Vanguard Group rather than a strategic investment decision or a reflection of Nu Skin's performance.

Future Outlook

NA

Management Comments

• The Vanguard Group, Inc. underwent an internal realignment on January 12, 2026, leading to certain subsidiaries or business divisions reporting beneficial ownership separately.
• These disaggregated entities will continue to pursue the same investment strategies as previously.
• The Vanguard Group, Inc. no longer holds or is deemed to hold beneficial ownership over securities now reported by these subsidiaries/divisions.

Industry Context

StockSavvy.ai notes that such internal realignments are common among large asset managers like Vanguard, often aimed at optimizing reporting structures or aligning with specific regulatory interpretations. This particular filing reflects a change in how Vanguard reports its aggregate holdings rather than a strategic shift in its investment thesis regarding Nu Skin, as the underlying investment strategies remain consistent across its disaggregated entities.

Stakeholder Impact

• Shareholders of Nu Skin: No direct impact on Nu Skin's operations or value, but a change in how a major institutional investor's holdings are reported.
• Investors tracking Vanguard's aggregate holdings: Will need to consider the disaggregated reports from Vanguard's subsidiaries for a complete picture of Vanguard's overall exposure to Nu Skin.

Key Dates

Keywords

Nu Skin Enterprises, Vanguard Group, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Investment Adviser, Institutional Ownership